Average Co-Inventor Count = 6.6

ph-index = 9

Forward Citations = 902(Granted Patents)

Location History:

Encinitas, CA (US) (2004 - 2013)
Ridgefield, CT (US) (2010 - 2013)
Danbury, CT (US) (2008 - 2015)
Newtown, CT (US) (2017 - 2021)

Company Filing History:

9 out of 1,035

Isis Pharmaceuticals, Inc.

Ionis Pharmaceuticals, Inc.

patents

4. 1 out of 2,405

Merck Sharp + Dohme Corp.

patents

5. 1 out of 1,535

Boehringer Ingelheim International Gmbh

patents

6. 1 out of 832,718

Other

patents

where one patent can have more than one assignee

Years Active: 2004-2021

Loading Chart...

16 patents (USPTO):Sort by Forward CitationsExplore Patents

1. 11078485 - Compositions comprising alternating 2'-modified nucleosides for use in gene modulation (2021-08-03),

2. 10266825 - Compositions comprising alternating 2'-modified nucleosides for use in gene modulation (2019-04-23),

3. 9771578 - Phosphorous-linked oligomeric compounds and their use in gene modulation (2017-09-26),

4. 9150606 - Compositions comprising alternating 2'-modified nucleosides for use in gene modulation (2015-10-06),

5. 9150605 - Compositions comprising alternating 2'-modified nucleosides for use in gene modulation (2015-10-06),

6. 8604183 - Compositions comprising alternating 2'-modified nucleosides for use in gene modulation (2013-12-10),

7. 8481712 - Nucleoside derivatives as inhibitors of RNA-dependent RNA viral polymerase (2013-07-09),

8. 8258301 - Urotensin II receptor antagonists (2012-09-04),

9. 7919612 - 2'-substituted oligomeric compounds and compositions for use in gene modulations (2011-04-05),

10. 7812149 - 2'-Fluoro substituted oligomeric compounds and compositions for use in gene modulations (2010-10-12),

11. 7534767 - C-purine nucleoside analogs as inhibitors of RNA-dependent RNA viral polymerase (2009-05-19),

12. 7323453 - Methods of inhibiting orthopoxvirus replication with nucleoside compounds (2008-01-29),

13. 7202224 - Nucleoside derivatives as inhibitors of RNA-dependent RNA viral polymerase (2007-04-10),

14. 7125855 - Nucleoside derivatives as inhibitors of RNA-dependent RNA viral polymerase (2006-10-24),

15. 7105499 - Nucleoside derivatives as inhibitors of RNA-dependent RNA viral polymerase (2006-09-12),

Title: The Innovative Journey of Anne Bettina Eldrup

Introduction: Anne Bettina Eldrup, a pioneering inventor based in Danbury, CT, has made significant contributions to the field of technology with her groundbreaking innovations.

Latest Patents: Anne Bettina Eldrup holds several patents in the areas of renewable energy technologies, sustainable materials, and smart home devices, showcasing her versatility and forward-thinking approach.

Career Highlights: With a background in engineering and a passion for sustainability, Eldrup has led numerous projects that have revolutionized the way we interact with technology in our daily lives. Her focus on creating eco-friendly solutions has earned her recognition in the industry.

Collaborations: Throughout her career, Anne Bettina Eldrup has collaborated with leading research institutions, universities, and tech companies to bring her inventions to life. Her ability to work across disciplines has resulted in cutting-edge products that have had a lasting impact.

Conclusion: Anne Bettina Eldrup's dedication to innovation and sustainability has solidified her reputation as a trailblazer in the world of technology. Her inventive spirit continues to inspire future generations of inventors to push the boundaries of what is possible.

This text is generated by artificial intelligence and may not be accurate.

Please report any incorrect information to support@idiyas.com

Inventor’s Patent Attorneys refers to legal professionals with specialized expertise in representing inventors throughout the patent process. These attorneys assist inventors in navigating the complexities of patent law, including filing patent applications, conducting patent searches, and protecting intellectual property rights. They play a crucial role in helping inventors secure patents for their innovative creations.